Table 3.

Estimated pain intensity (VRS) and maximum/minimum pain (NRS) recorded in the subgroups of “inflammatory central neuropathy”—“central neuropathic pain due to trauma”—“fibromyalgia” prior to and during/after delta 9-THC therapy. No significant differences between the groups could be analysed. In each group, delta 9-THC medication caused a noticeable amelioration of pain.

	Inflammatory central neuropathy		Central neuropathy due to trauma		Fibromyalgia
	Prior to	After	Prior to	After	Prior to	After
	Delta 9-THC medication		Delta 9-THC medication		Delta 9-THC medication
Pain intensity	7.6 ± 1.7	4.2 ± 1.9	7.6 ± 1.4	3.8 ± 1.5	7.9 ± 1.5	4.4 ± 1.5
(VRS, 0–10)
Max. pain	7.6 ± 1.7	4.9 ± 2.4	9.3 ± 1	5.3 ± 1.7	9.3 ± 1.1	6.1 ± 2.1
(NRS, 0–10)
Min. pain	5.4 ± 1.8	2.1 ± 1.5	6.0 ± 1	2.9 ± 1.9	6.6 ± 2	3.0 ± 1.8
(NRS, 0–10)